Ofloxacin Ophthalmic
10 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
10
Total Reports
1
Deaths Reported
1000.0%
Death Rate
Active Ingredients
Ofloxacin Ophthalmic
Administration Routes
IntraocularOphthalmicUnknownTopical
Species Affected
Dog 8
Cat 2
Most Affected Breeds
Retriever - Golden 3
Shar Pei 1
Dachshund (unspecified) 1
Rottweiler 1
Domestic Shorthair 1
Crossbred Canine/dog 1
Catahoula Leopard Dog 1
Siamese 1
Most Reported Reactions
Disorientation 2
Hypoglycaemia 2
Lethargy (see also Central nervous system depression in 'Neurological') 2
Restlessness 2
Injection site lump 1
Blepharospasm 1
Decreased appetite 1
Hyperglycaemia 1
Weight loss 1
Excessive thirst 1
Disoriented state 1
Other abnormal test result NOS 1
Outcome Breakdown
Recovered/Normal
6 (60.0%)
Ongoing
2 (20.0%)
Outcome Unknown
1 (10.0%)
Euthanized
1 (10.0%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.